Laboratory of Neuro-Trauma and Neurodegenerative Disorders, Tianjin Geriatrics Institute, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Department of Geriatrics, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Neurochem Res. 2019 Aug;44(8):1903-1923. doi: 10.1007/s11064-019-02825-1. Epub 2019 Jun 12.
In our recent study, we observed consistent increases in miR-124-3p levels in exosomes derived from cultured BV2 microglia which was treated with repetitive traumatic brain injury (rTBI) mouse model brain extracts. To clarify the mechanisms underlying increases in microglia-derived exosomal miR-124-3p and their role in regulating neuronal autophagy after TBI, we investigated the impact of exosomal miR-124-3p on neuronal autophagy in scratch-injured HT22 neurons and rTBI mice. We harvested injured brain extracts from rTBI mice at 3 to 21 days post injury (DPI) for the treatment of cultured BV2 microglia in vitro. We observed significant induction of autophagy following TBI in vitro, and that inhibition of activated neuronal autophagy could protect against trauma-induced injury. Our results indicated that co-culture of injured HT22 neurons with miR-124-3p overexpressing BV2 microglia exerted a protective effect by inhibiting neuronal autophagy in scratch-injured neurons. Further research revealed that these effects were achieved mainly via upregulation of exosomal miR-124-3p, and that Focal adhesion kinase family-interacting protein of 200 kDa (FIP200) plays a key role in trauma-induced autophagy. Injection of exosomes into the vena caudalis in in vivo experiments revealed that exosomal miR-124-3p was associated with decreases in the modified neurological severity score (mNSS) and improvements in Morris water maze (MWM) test results in rTBI mice. Altogether, our results indicate that increased miR-124-3p in microglial exosomes following TBI may inhibit neuronal autophagy and protect against nerve injury via their transfer into neurons. Thus, treatment with microglial exosomes enriched with miR-124-3p may represent a novel therapeutic strategy for the treatment of nerve injury after TBI.
在我们最近的研究中,我们观察到源自重复创伤性脑损伤(rTBI)小鼠模型脑提取物处理的培养的 BV2 小胶质细胞衍生的外泌体中 miR-124-3p 水平持续增加。为了阐明小胶质细胞衍生的外泌体 miR-124-3p 增加的机制及其在 TBI 后调节神经元自噬的作用,我们研究了外泌体 miR-124-3p 对划痕损伤 HT22 神经元和 rTBI 小鼠中神经元自噬的影响。我们从 rTBI 小鼠受伤后 3 至 21 天(DPI)收获受伤的脑提取物,用于体外培养的 BV2 小胶质细胞处理。我们观察到体外 TBI 后自噬明显诱导,并且抑制激活的神经元自噬可以防止创伤引起的损伤。我们的结果表明,与过表达 miR-124-3p 的 BV2 小胶质细胞共培养的受伤 HT22 神经元通过抑制划痕损伤神经元中的神经元自噬发挥保护作用。进一步的研究表明,这些作用主要是通过上调外泌体 miR-124-3p 实现的,并且粘着斑激酶家族相互作用蛋白 200kDa(FIP200)在创伤诱导的自噬中发挥关键作用。在体内实验中向尾静脉注射外泌体表明,外泌体 miR-124-3p 与 rTBI 小鼠改良神经功能严重程度评分(mNSS)降低和 Morris 水迷宫(MWM)测试结果改善相关。总之,我们的结果表明,TBI 后小胶质细胞外泌体中 miR-124-3p 的增加可能通过将其转移到神经元中来抑制神经元自噬并保护神经免受损伤。因此,用富含 miR-124-3p 的小胶质细胞外泌体治疗可能代表治疗 TBI 后神经损伤的一种新的治疗策略。
J Neurochem. 2025-8
Stem Cell Res Ther. 2025-5-28
Cell Mol Neurobiol. 2024-12-9
Cell Mol Life Sci. 2018-8-28
J Neurosci Methods. 2018-8-1
Mol Neurobiol. 2018-4-16
Neuroscience. 2018-4-13
Oncotarget. 2017-12-9
Lancet Public Health. 2016-11-29
Neural Regen Res. 2017-11